Nektar Therapeutics
NKTR
#6000
Rank
NZ$1.95 B
Marketcap
NZ$57.05
Share price
-3.66%
Change (1 day)
-46.93%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): NZ-$11.63

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$12.19. In 2025 the company made an earnings per share (EPS) of NZ-$18.56 a decrease over its 2024 EPS that were of NZ-$16.12.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$11.63-37.35%
2025NZ-$18.5615.12%
2024NZ-$16.12-59.54%
2023NZ-$39.85-25.89%
2022NZ-$53.78-31.12%
2021NZ-$78.0714.86%
2020NZ-$67.97-1.19%
2019NZ-$68.79-163.96%
2018NZ$107.55-725.4%
2017NZ-$17.20-42.73%
2016NZ-$30.0383.33%
2015NZ-$16.3839.53%
2014NZ-$11.74-69.29%
2013NZ-$38.22-6.67%
2012NZ-$40.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.63-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.57-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.96-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$1.09-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland